[Vasin new fluoroquinolones in treatment of patients with infectious lesions in diabetic foot syndrome]

MeSH terms

• Anti-Bacterial Agents / administration & dosage
• Anti-Bacterial Agents / adverse effects
• Anti-Bacterial Agents / classification
• Combined Modality Therapy
• Diabetic Foot / drug therapy*
• Diabetic Foot / microbiology
• Diabetic Foot / physiopathology
• Diabetic Foot / surgery
• Dose-Response Relationship, Drug
• Drug Monitoring
• Drug Therapy, Combination
• Female
• Fluoroquinolones* / administration & dosage
• Fluoroquinolones* / adverse effects
• Humans
• Male
• Middle Aged
• Moxifloxacin
• Severity of Illness Index
• Staphylococcal Infections* / drug therapy
• Staphylococcal Infections* / physiopathology
• Staphylococcal Infections* / surgery
• Staphylococcus aureus* / drug effects
• Staphylococcus aureus* / isolation & purification
• Surgical Procedures, Operative / methods*
• Treatment Outcome